Legend Biotech (LEGN) News Today $39.61 +0.69 (+1.77%) As of 02:10 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Legend Biotech Corporation (LEGN): One of the Most Oversold Healthcare Stocks to Buy NowFebruary 20 at 2:54 PM | msn.comAlberta Investment Management Corp Has $4.40 Million Position in Legend Biotech Co. (NASDAQ:LEGN)Alberta Investment Management Corp boosted its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 143.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 135,259 shares of the companyFebruary 20 at 4:54 AM | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Shares Sold by TimesSquare Capital Management LLCTimesSquare Capital Management LLC trimmed its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 99.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,912 shares of the company's stocFebruary 20 at 4:53 AM | marketbeat.comEmpire Life Investments Inc. Acquires 38,043 Shares of Legend Biotech Co. (NASDAQ:LEGN)Empire Life Investments Inc. lifted its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 38.5% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 136,731 shares of the company's stock after buying an additional 3February 16, 2025 | marketbeat.comIs Legend Biotech (LEGN) the Best Mid-Cap Growth Stock to Buy According to Analysts?February 14, 2025 | msn.comMirae Asset Global Investments Co. Ltd. Sells 13,850 Shares of Legend Biotech Co. (NASDAQ:LEGN)Mirae Asset Global Investments Co. Ltd. decreased its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 48.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,February 13, 2025 | marketbeat.comWhy Legend Biotech Corporation (LEGN) Is Among the Best Healthcare Stocks To Buy According to AnalystsFebruary 8, 2025 | msn.comExane Asset Management Invests $2.28 Million in Legend Biotech Co. (NASDAQ:LEGN)Exane Asset Management acquired a new stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 67,782 shares of the company's stock, valued at approximately $2,284,000. Legend BiotechFebruary 8, 2025 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Given Average Rating of "Buy" by BrokeragesLegend Biotech Co. (NASDAQ:LEGN - Get Free Report) has earned an average recommendation of "Buy" from the twelve research firms that are covering the stock, MarketBeat Ratings reports. Twelve investment analysts have rated the stock with a buy rating. The average 12-month price objective among broFebruary 3, 2025 | marketbeat.comSG Americas Securities LLC Raises Position in Legend Biotech Co. (NASDAQ:LEGN)SG Americas Securities LLC boosted its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 276.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,417 shares of the companFebruary 1, 2025 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Short Interest UpdateLegend Biotech Co. (NASDAQ:LEGN - Get Free Report) was the recipient of a large drop in short interest during the month of January. As of January 15th, there was short interest totalling 13,110,000 shares, a drop of 37.3% from the December 31st total of 20,900,000 shares. Based on an average daily volume of 1,480,000 shares, the days-to-cover ratio is presently 8.9 days.January 31, 2025 | marketbeat.comHere’s Why Legend Biotech Corporation (LEGN) Will Double in 2025January 31, 2025 | msn.comMatthews International Capital Management LLC Has $38.58 Million Stake in Legend Biotech Co. (NASDAQ:LEGN)Matthews International Capital Management LLC boosted its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 14.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,185,516 shares of the company'January 28, 2025 | marketbeat.comLegend Biotech's SWOT analysis: carvykti's efficacy drives stock potential amid competitionJanuary 27, 2025 | msn.comBarclays Keeps Their Buy Rating on Legend Biotech (LEGN)January 27, 2025 | markets.businessinsider.comE Fund Management Hong Kong Co. Ltd. Has $1.40 Million Stock Position in Legend Biotech Co. (NASDAQ:LEGN)E Fund Management Hong Kong Co. Ltd. reduced its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 19.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 43,080 shares of the company's stock after selling 10,630 sJanuary 27, 2025 | marketbeat.comQ4 EPS Estimates for Legend Biotech Raised by HC WainwrightLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Investment analysts at HC Wainwright boosted their Q4 2024 earnings per share (EPS) estimates for Legend Biotech in a research note issued on Thursday, January 23rd. HC Wainwright analyst M. Kapoor now expects that the company will earn ($0.30) perJanuary 27, 2025 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Shares Down 3.5% - Should You Sell?Legend Biotech (NASDAQ:LEGN) Shares Down 3.5% - Here's What HappenedJanuary 24, 2025 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Shares Gap Up - Time to Buy?Legend Biotech (NASDAQ:LEGN) Shares Gap Up - What's Next?January 24, 2025 | marketbeat.comStrong Buy Recommendation for Legend Biotech Amidst Robust Sales and Strategic ExpansionsJanuary 23, 2025 | markets.businessinsider.comAnalysts Issue Forecasts for Legend Biotech FY2024 EarningsLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Research analysts at William Blair reduced their FY2024 EPS estimates for Legend Biotech in a research note issued to investors on Tuesday, January 21st. William Blair analyst S. Corwin now expects that the company will post earnings of ($1.45) perJanuary 23, 2025 | marketbeat.comLegend Biotech price target lowered to $84.28 from $92.97 at Goldman SachsJanuary 23, 2025 | markets.businessinsider.comOncology Experts Predict 2025 Will Be a Year of Breakthroughs in Treatment and PreventionJanuary 22, 2025 | baystreet.caLegend Biotech’s Carvykti Receives Buy Rating Amid Improved Safety Profile and Projected Sales GrowthJanuary 22, 2025 | markets.businessinsider.comLegend Biotech stock target cut to $91 by JefferiesJanuary 22, 2025 | msn.comLegend Biotech (NASDAQ:LEGN) Shares Gap Up - Here's WhyLegend Biotech (NASDAQ:LEGN) Shares Gap Up - Here's WhyJanuary 22, 2025 | marketbeat.comCantor Fitzgerald Estimates Legend Biotech FY2025 EarningsLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for Legend Biotech in a report released on Tuesday, January 21st. Cantor Fitzgerald analyst R. Bienkowski forecasts that the company will post earnings of ($0.72)January 22, 2025 | marketbeat.comLegend Biotech keeps stock at Buy rating on strong positionJanuary 21, 2025 | msn.comLegend Biotech: Strong Buy Rating Driven by Competitive Positioning of CARVYKTI Amidst Safety and Regulatory ConfidenceJanuary 21, 2025 | markets.businessinsider.comLegend Biotech's (LEGN) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $73.00 price objective on shares of Legend Biotech in a research note on Tuesday.January 21, 2025 | marketbeat.comShort Interest in Legend Biotech Co. (NASDAQ:LEGN) Decreases By 8.9%Legend Biotech Co. (NASDAQ:LEGN - Get Free Report) was the recipient of a significant decline in short interest during the month of December. As of December 31st, there was short interest totalling 20,900,000 shares, a decline of 8.9% from the December 15th total of 22,950,000 shares. Based on an average daily volume of 1,520,000 shares, the short-interest ratio is currently 13.8 days.January 18, 2025 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Trading 6.7% Higher - What's Next?Legend Biotech (NASDAQ:LEGN) Trading 6.7% Higher - What's Next?January 17, 2025 | marketbeat.comLegend Biotech Corporation (LEGN): The Biotech Stock with Biggest Upside PotentialJanuary 17, 2025 | msn.comLegend Biotech's SWOT analysis: carvykti's strong sales fuel stock's potentialJanuary 16, 2025 | msn.comLegend Biotech (NASDAQ:LEGN) Trading Down 9.3% - What's Next?Legend Biotech (NASDAQ:LEGN) Stock Price Down 9.3% - Here's What HappenedJanuary 15, 2025 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Stock Price Down 9.3% - Here's What HappenedLegend Biotech (NASDAQ:LEGN) Shares Down 9.3% - Here's WhyJanuary 13, 2025 | marketbeat.comLegend Biotech rumor highlighted in Betaville alertJanuary 11, 2025 | markets.businessinsider.comLegend Biotech (NASDAQ:LEGN) Sets New 12-Month Low - Here's WhyLegend Biotech (NASDAQ:LEGN) Reaches New 12-Month Low - What's Next?January 10, 2025 | marketbeat.comNordea Investment Management AB Increases Stock Position in Legend Biotech Co. (NASDAQ:LEGN)Nordea Investment Management AB increased its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 14.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 266,232 shares of the company's stock after acquiring anJanuary 10, 2025 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Given Consensus Recommendation of "Buy" by AnalystsShares of Legend Biotech Co. (NASDAQ:LEGN - Get Free Report) have earned an average rating of "Buy" from the thirteen brokerages that are currently covering the company, Marketbeat.com reports. Thirteen investment analysts have rated the stock with a buy recommendation. The average 1-year price obJanuary 9, 2025 | marketbeat.comLegend Biotech Corp ADRJanuary 7, 2025 | morningstar.comPromising Growth Trajectory and Market Expansion Justify Buy Rating for Legend BiotechJanuary 7, 2025 | markets.businessinsider.comLegend Biotech price target lowered to $84 from $86 at RBC CapitalJanuary 7, 2025 | markets.businessinsider.comTop 5 Commercial Biotech Buyout Candidates: Legend Biotech (No. 4)January 7, 2025 | seekingalpha.comPiper lowers sales estimates for Legend Biotech’s CarvyktiDecember 30, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and NewAmsterdam Pharma Company (NAMS)December 30, 2024 | markets.businessinsider.comBreaking Down Legend Biotech: 9 Analysts Share Their ViewsDecember 30, 2024 | benzinga.comLegend Biotech (NASDAQ:LEGN) Given "Overweight" Rating at Piper SandlerPiper Sandler restated an "overweight" rating and issued a $78.00 price target on shares of Legend Biotech in a report on Monday.December 30, 2024 | marketbeat.comGeode Capital Management LLC Has $23.93 Million Stake in Legend Biotech Co. (NASDAQ:LEGN)Geode Capital Management LLC grew its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 3.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 494,864 shares of the company's stock after buying an additional 17,3December 28, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Reaches New 1-Year Low - What's Next?Legend Biotech (NASDAQ:LEGN) Hits New 52-Week Low - What's Next?December 24, 2024 | marketbeat.com Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address LEGN Media Mentions By Week LEGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LEGN News Sentiment▼1.360.60▲Average Medical News Sentiment LEGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LEGN Articles This Week▼46▲LEGN Articles Average Week Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TEVA News SMMT News GMAB News ITCI News VTRS News MRNA News RDY News PCVX News SRPT News QGEN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LEGN) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Legend Biotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Legend Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
